Home Biosimilar Antibodies Metabolism Others Farletuzumab-MMAE For research use only.
Not for use in humans.

Farletuzumab-MMAE

Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.

Farletuzumab-MMAE

CAS No.

Click to purchase the isotype control of Farletuzumab-MMAE

Purity & Quality Control

Batch: D401501 Purity: 99% Protein concentration: 5.59mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.

Product Details

ADC antiody Farletuzumab
ADC cytotoxin MMAE
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Farletuzumab-MMAE | Farletuzumab-MMAE supplier | purchase Farletuzumab-MMAE | Farletuzumab-MMAE cost | Farletuzumab-MMAE manufacturer | order Farletuzumab-MMAE | Farletuzumab-MMAE distributor